ArticleJournal of cancer research and clinical oncology2019

Does sunitinib have a patient-specific dose without diminishing its antitumor effect on advanced pancreatic neuroendocrine neoplasms?

Satoshi Matsui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.